Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Endocrine 1

Conditions

Prostate Cancer Recurrent 1Multiple Endocrine Neoplasia Type 1 1Hypogonadism 1

Interventions

Exercise 419Blood Specimen Collection 319Standard of Care 299Surveys and Questionnaires 242Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 101Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER × testosterone undecanoate × Clear all
NCT04134130 2020-01-22

The Role of Follicle Stimulating Hormone in Advanced Prostate Cancer

Lund University

Phase NA Completed
33 enrolled
Genitourinary

Prostate Cancer Recurrent

NCT00119483 2011-09-05

Older Men and Testosterone

University Hospital of North Norway

Phase NA Completed
200 enrolled
Endocrine

Hypogonadism, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡